Keith Lamont Cummings - Sep 3, 2021 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Financial Officer
Signature: /s/ Mike Ouimette, attorney-in-fact
Stock symbol: PLRX
Transactions as of: Sep 3, 2021
Transactions value $: $41,600
Form type: 4
Date filed: 9/3/2021, 06:27 PM
Next filing: Feb 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Options Exercise	$41.6K	+20K	+42%	$2.08^*	67.6K	Sep 3, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (right to buy)	Options Exercise	$0	-20K	-11.76%	$0.00	150K	Sep 3, 2021	Common Stock	20K	$2.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.